These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30385172)

  • 61. Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Chen K; Li S; Chen M; Jin Z; Sun X; Zhou S; Yang H
    BMC Cancer; 2024 Feb; 24(1):257. PubMed ID: 38395838
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
    Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
    Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer.
    Baker S; Bakunina K; Duijm M; Hoogeman MS; Cornelissen R; Antonisse I; Praag J; Heemsbergen WD; Nuyttens JJ
    Radiat Oncol; 2020 Apr; 15(1):89. PubMed ID: 32321553
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy.
    Qiu J; Ke D; Lin H; Yu Y; Zheng Q; Li H; Zheng H; Liu L; Li J
    Front Oncol; 2022; 12():898653. PubMed ID: 36483030
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
    Ye L; Shi S; Zeng Z; Huang Y; Hu Y; He J
    Jpn J Clin Oncol; 2018 Feb; 48(2):160-166. PubMed ID: 29253245
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
    Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
    Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
    Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of clinical and physical dosimetric factors that determine the outcome of severe acute radiation pneumonitis in lung cancer patients.
    Zhao J; Ma C; Gan G; Xu X; Zhou J
    Radiat Oncol; 2023 Aug; 18(1):143. PubMed ID: 37644602
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
    Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
    Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients.
    Zhang B; Yuan Z; Zhao L; Pang Q; Wang P
    Oncotarget; 2017 Jun; 8(23):37208-37216. PubMed ID: 28388538
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery.
    Dang J; Li G; Zang S; Zhang S; Yao L
    Lung Cancer; 2014 Dec; 86(3):329-33. PubMed ID: 25454199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.
    Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q
    Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lung Size and the Risk of Radiation Pneumonitis.
    Briere TM; Krafft S; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis.
    Inoue A; Kunitoh H; Sekine I; Sumi M; Tokuuye K; Saijo N
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):649-55. PubMed ID: 11172945
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
    Wang D; Zhu J; Sun J; Li B; Wang Z; Wei L; Yin Y; Sun H; Fu Z; Zhang X; Huo Z
    Clin Transl Oncol; 2012 Dec; 14(12):943-52. PubMed ID: 22855174
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
    Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
    Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk factors of radiation pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapy--Are we underestimating diabetes?--Turkish oncology group (TOG)/Lung cancer study group.
    Ergen SA; Dincbas FO; Yücel B; Altınok P; Akyurek S; Korkmaz Kıraklı E; Ulger S; Etiz D; Yilmaz U; Kılıc D; Bozcuk H
    Clin Respir J; 2020 Sep; 14(9):871-879. PubMed ID: 32470205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.